Literature DB >> 16091986

Normotensive pheochromocytoma: institutional experience.

Amit Agarwal1, Sushil Gupta, Anand Kumar Mishra, Nikhil Singh, Saroj K Mishra.   

Abstract

We report an audit of nine cases of subclinical or normotensive pheochromocytoma managed in our department. This is the first report from India of such a series. During the period 1990-2003 a total of 45 patients of pheochromocytoma were diagnosed and managed in the Department of Endocrine Surgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences. Among them, nine patients were diagnosed as having subclinical or normotensive pheochromocytoma. Inclusion criteria for normotensive pheochromocytoma were: no previous history of hypertension clinically and, in the previous treatment documents, any episode of symptoms suggesting high blood pressure. The demographic profile, clinical presentation, biochemical investigations, imaging results, surgical notes, and follow-up record were reviewed retrospectively. All patients had a primary complaint of flank/abdominal pain and were normotensive. Seven had elevated urinary metanephrine levels, and one patient had normal values. One patient did not undergo the urinary metanephrine assay. Imaging of the abdomen showed seven adrenal and two extra-adrenal masses (eight had computed tomography scans of the abdomen, and one underwent ultrasonography). After selective alpha-adrenergic blockade (prazosin), surgery was performed. Six patients required infusion of sodium nitroprusside intraoperatively. The final histopathology was pheochromocytoma in all patients. Metanephrine levels were normal during the follow-up. Normotensive pheochromocytomas are a distinct entity, and all adrenal incidentalomas should be investigated for catecholamine hypersecretion. We support the use of preoperative alpha-adrenergic blockade, and these patients should be treated along the same lines as hypertensive pheochromocytoma.

Entities:  

Mesh:

Year:  2005        PMID: 16091986     DOI: 10.1007/s00268-005-7839-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  11 in total

1.  Plasma 3,4-dihydroxyphenylalanine (dopa) and catecholamines in neuroblastoma or pheochromocytoma.

Authors:  D S Goldstein; R Stull; G Eisenhofer; J C Sisson; A Weder; S D Averbuch; H R Keiser
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

2.  The anesthetic management of pheochromocytoma effect of preoperative adrenergic blocking drugss.

Authors:  L B Perry; A B Gould
Journal:  Anesth Analg       Date:  1972 Jan-Feb       Impact factor: 5.108

3.  Desensitization of postjunctional alpha 1- and alpha 2-adrenergic receptor-mediated vasopressor responses in rat harboring pheochromocytoma.

Authors:  G Tsujimoto; K Honda; B B Hoffman; K Hashimoto
Journal:  Circ Res       Date:  1987-07       Impact factor: 17.367

4.  Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine.

Authors:  G A Smythe; G Edwards; P Graham; L Lazarus
Journal:  Clin Chem       Date:  1992-04       Impact factor: 8.327

5.  Successful outcomes in pheochromocytoma surgery in the modern era.

Authors:  J C Ulchaker; D A Goldfarb; E L Bravo; A C Novick
Journal:  J Urol       Date:  1999-03       Impact factor: 7.450

6.  Blood pressure regulation in pheochromocytoma.

Authors:  E L Bravo; R C Tarazi; F M Fouad; S C Textor; R W Gifford; D G Vidt
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

7.  Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.

Authors:  E L Bravo; R C Tarazi; R W Gifford; B H Stewart
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

Review 8.  Pheochromocytoma.

Authors:  E L Bravo; R W Gifford
Journal:  Endocrinol Metab Clin North Am       Date:  1993-06       Impact factor: 4.741

9.  Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumors and plasma of pheochromocytoma patients.

Authors:  J M Lundberg; T Hökfelt; A Hemsén; E Theodorsson-Norheim; J Pernow; B Hamberger; M Goldstein
Journal:  Regul Pept       Date:  1986-01

10.  Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series.

Authors:  M G Sutton; S G Sheps; J T Lie
Journal:  Mayo Clin Proc       Date:  1981-06       Impact factor: 7.616

View more
  9 in total

1.  Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family.

Authors:  Ping Yuan; Qipeng Sun; Hao Liang; Wenjun Wang; Ling Li; Ye Wang; Huan Deng; Luhua Lai; Xiaoli Chen; Xiangfu Zhou
Journal:  Cancer Biol Ther       Date:  2016-04-08       Impact factor: 4.742

2.  Successful Management of Phaeochromocytoma using Preoperative Oral Labetalol and Intraoperative Magnesium Sulphate: Report of four cases.

Authors:  S B Sanath Kumar; Rohit Date; Nicholas Woodhouse; Omayma El-Shafie; Karin Nollain
Journal:  Sultan Qaboos Univ Med J       Date:  2014-04-07

3.  Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy?

Authors:  Amit Agarwal; Prateek K Mehrotra; Manoj Jain; Sushil K Gupta; Anjali Mishra; Gyan Chand; Gaurav Agarwal; A K Verma; S K Mishra; Uttam Singh
Journal:  World J Surg       Date:  2010-12       Impact factor: 3.352

4.  Intraoperative diagnosis of functional retroperitoneal multiple paraganglioma: A case report.

Authors:  Qingqu Guo; Baozhong Li; Jianyun Guan; Haijun Yang; Yulian Wu
Journal:  Oncol Lett       Date:  2012-07-10       Impact factor: 2.967

5.  Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study.

Authors:  Henrique Vara Luiz; Mary Jane Tanchee; Maria G Pavlatou; Run Yu; Joan Nambuba; Katherine Wolf; Tamara Prodanov; Robert Wesley; Karen Adams; Tito Fojo; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2016-04-15       Impact factor: 3.478

Review 6.  Update on Modern Management of Pheochromocytoma and Paraganglioma.

Authors:  Jacques W M Lenders; Graeme Eisenhofer
Journal:  Endocrinol Metab (Seoul)       Date:  2017-06

7.  Hemodynamic instability during percutaneous ablation of extra-adrenal metastases of pheochromocytoma and paragangliomas: a case series.

Authors:  Atousa Deljou; Jacob D Kohlenberg; Toby N Weingarten; Irina Bancos; William F Young; Darrell R Schroeder; David P Martin; Juraj Sprung
Journal:  BMC Anesthesiol       Date:  2018-11-06       Impact factor: 2.217

8.  Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1.

Authors:  Ahmed Al-Sharefi; Usman Javaid; Petros Perros; John Ealing; Peter Truran; Sath Nag; Shafie Kamaruddin; Kamal Abouglila; Fiona Cains; Lauren Lewis; Robert Andrew James
Journal:  Eur Endocrinol       Date:  2019-08-16

Review 9.  Perioperative Management of Pheochromocytomas and Sympathetic Paragangliomas.

Authors:  Gustavo F C Fagundes; Madson Q Almeida
Journal:  J Endocr Soc       Date:  2022-01-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.